| Literature DB >> 35945511 |
Philippe Tuppin1, Thomas Lesuffleur2, Panayotis Constantinou2, Alice Atramont2, Carole Coatsaliou2, Emilie Ferrat3,4, Florence Canouï-Poitrine3,5, Gonzague Debeugny2, Antoine Rachas2.
Abstract
BACKGROUND: The organization of healthcare systems changed significantly during the COVID-19 pandemic. The impact on the use of primary care during various key periods in 2020 has been little studied.Entities:
Keywords: Ambulatory healthcare use; COVID-19; Chronic diseases; Deaths; Epidemic trends; France; Lockdown; Observational study
Mesh:
Year: 2022 PMID: 35945511 PMCID: PMC9361264 DOI: 10.1186/s12875-022-01792-x
Source DB: PubMed Journal: BMC Prim Care ISSN: 2731-4553
Fig. 1Change in the weekly number of people with at least one consultation in 2020 relative to the same week in 2019, by type of healthcare professional, for mainland France. First national lockdown W11-W18 (March 17 to May 10, 2020), Second national lockdown W44-W49 (October 30 to December 14, 2020). Weekly rates of new hospitalizations for COVID-19, used as a marker of epidemic intensity
Fig. 2Weekly proportion of total consultations in the form of teleconsultation in mainland France in 2020, by specialty. First national lockdown W11-W18 (March 17 to May 10, 2020). Second national lockdown W44-W49 (October 30 to December 14, 2020)
Description of the use of primary healthcare during the lockdown periods throughout the whole of 2020 relative to the corresponding periods in 2019 in mainland France
| % | % | % | % | % | % | % | % | % | mean | mean | mean | mean | mean | mean | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Generalist | 26.0 | 33.6 | 80.1 | -34 | -7 | -3 | -32 | -5 | -8 | 1.6 | 1.6 | 1.5 | 1.5 | 4.9 | 4.6 |
| Nurse | 7.4 | 15.2 | 41.5 | -28 | + 39 | + 29 | -7 | + 9 | + 5 | 8.8 | 11.5 | 7.1 | 5.6 | 18.6 | 15.1 |
| Dentist | 0.5 | 9.8 | 37.1 | -95 | + 1 | -12 | -96 | + 2 | -17 | 1.4 | 1.1 | 1.3 | 1.3 | 2.3 | 2.1 |
| Physiotherapist | 1.6 | 6.7 | 15.2 | -80 | -3 | -8 | -85 | + 6 | -14 | 8.0 | 5.8 | 7.3 | 8.0 | 23.8 | 22.2 |
| Midwife | 0.5 | 0.9 | 2.9 | -39 | + 19 | + 10 | -44 | + 16 | 0 | 2.9 | 2.6 | 2.6 | 2.6 | 6.0 | 5.4 |
| Ophthalmologist | 1.0 | 5.4 | 26.7 | -82 | + 4 | -7 | -82 | + 4 | -10 | 1.1 | 1.1 | 1.1 | 1.1 | 1.5 | 1.4 |
| Gynecologist | 1.1 | 2.4 | 10.2 | -59 | + 4 | -9 | -55 | + 5 | -10 | 1.3 | 1.4 | 1.2 | 1.2 | 1.9 | 1.9 |
| Cardiologist | 1.0 | 2.1 | 9.6 | -55 | + 2 | -5 | -55 | + 2 | -8 | 1.4 | 1.4 | 1.3 | 1.3 | 2.0 | 1.9 |
| Dermatologist | 0.7 | 1.8 | 9.0 | -66 | -1 | -12 | -67 | 0 | -14 | 1.1 | 1.1 | 1.1 | 1.1 | 1.5 | 1.5 |
| ENT | 0.5 | 1.2 | 6.3 | -69 | -4 | -11 | -69 | -3 | -14 | 1.1 | 1.1 | 1.1 | 1.1 | 1.6 | 1.5 |
| Gastroenterologist | 0.3 | 0.9 | 3.9 | -66 | + 4 | -7 | -65 | + 4 | -10 | 1.3 | 1.4 | 1.3 | 1.3 | 1.9 | 1.9 |
| Pediatrician | 0.7 | 0.9 | 3.6 | -45 | -8 | -4 | -46 | -11 | -13 | 1.4 | 1.3 | 1.3 | 1.3 | 2.9 | 2.7 |
| Rheumatologist | 0.4 | 0.8 | 3.2 | -61 | + 2 | -10 | -62 | + 3 | -14 | 1.3 | 1.2 | 1.2 | 1.2 | 2.1 | 2.0 |
| Pulmonologist | 0.3 | 0.6 | 2.8 | -50 | + 3 | -4 | -48 | + 2 | -7 | 1.3 | 1.3 | 1.2 | 1.2 | 1.8 | 1.8 |
| Psychiatrist | 0.8 | 1.2 | 2.4 | -37 | -1 | -4 | -25 | + 3 | -5 | 3.0 | 3.5 | 2.7 | 2.8 | 10.1 | 10.0 |
| Endocrinologist | 0.2 | 0.4 | 1.6 | -46 | + 7 | -4 | -44 | + 8 | -5 | 1.1 | 1.2 | 1.1 | 1.1 | 1.9 | 1.9 |
LD 1: First national lockdown W11-W18 (March 17 to May 10, 2020)
LD 2: Second national lockdown W44-W49 (October 30 to December 14, 2020)
Reading grid: During the first lockdown, the percentage of people with at least one consultation with a general practitioner in 2020 was 26.0%, corresponding to a 34% decrease relative to 2019. There was also a 32% decrease in the overall number of consultations in 2020 relative to 2019. For those with at least one consultation during the study period, their mean number of consultations per person was 1.6 during the first lockdown in 2020
Description of person characteristics with at least one consultation with GPs and nurses during the lockdown periods and the whole of 2020 relative to the corresponding periods in 2019, for mainland France
| LD 1 | LD 2 | Year | LD 1 | LD 2 | Year | LD 1 | LD 2 | Year | LD 1 | LD 2 | Year | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020 Million | Mean | % | % | % | % | % | % | % | % | % | % | % | % | /100.000 | % | |
| 64.3 | 41.9 | 26.0 | 33.6 | 80.1 | -34 | -7 | -3 | 7.4 | 15.2 | 41.5 | -28 | + 39 | + 29 | 587.1 | + 9 | |
| 0–1 | 1.4 | - | 30.0 | 34.3 | 82.1 | -43 | -26 | -7 | 0.6 | 1.4 | 7.4 | -33 | + 64 | + 43 | 0.3 | -19 |
| 2–6 | 3.7 | - | 13.9 | 21.9 | 78.3 | -60 | -35 | -9 | 0.6 | 2.4 | 10.4 | -51 | + 136 | + 67 | 0.2 | -24 |
| 7–17 | 8.4 | - | 10.5 | 19.6 | 75.1 | -60 | -21 | -6 | 1.0 | 6.4 | 20.9 | -52 | + 212 | + 102 | 0.8 | -1 |
| 18–25 | 5.8 | - | 17.5 | 23.1 | 74.9 | -38 | -9 | -2 | 3.2 | 9.9 | 35.5 | -36 | + 120 | + 63 | 1.8 | -2 |
| 26–50 | 20.0 | - | 24.5 | 29.6 | 77.9 | -28 | -5 | -3 | 4.8 | 12.2 | 39.1 | -35 | + 82 | + 41 | 22.0 | -1 |
| 51–65 | 12.2 | - | 32.1 | 40.3 | 84.7 | -27 | -2 | -1 | 8.3 | 17.5 | 49.8 | -33 | + 37 | + 20 | 69.7 | + 3 |
| 66–75 | 6.9 | - | 36.3 | 49.2 | 89.8 | -30 | 0 | + 1 | 14.5 | 27.6 | 64.2 | -26 | + 14 | + 13 | 97.0 | + 11 |
| 76–85 | 4.2 | - | 43.6 | 54.5 | 90.0 | -28 | -1 | 0 | 23.8 | 35.2 | 71.1 | -20 | + 3 | + 6 | 170.4 | + 9 |
| > 85 | 1.8 | - | 41.6 | 46.1 | 77.4 | -23 | + 2 | + 3 | 29.2 | 33.5 | 61.2 | -7 | + 8 | + 10 | 224.7 | + 11 |
| Male | 30.7 | 40.6 | 23.3 | 29.7 | 77.1 | -33 | -8 | -3 | 6.5 | 13.6 | 37.2 | -26 | + 41 | + 34 | 296.1 | + 10 |
| Female | 33.5 | 43.1 | 28.4 | 37.1 | 84.0 | -34 | -6 | -2 | 8.2 | 16.7 | 45.3 | -29 | + 37 | + 25 | 290.9 | + 8 |
| Q1 (Most favored) | 12.6 | 41.2 | 22.0 | 29.7 | 77.9 | -38 | -9 | -4 | 5.8 | 12.9 | 39.0 | -30 | + 45 | + 38 | 95.0 | + 13 |
| Q2 | 12.9 | 41.2 | 25.6 | 33.3 | 81.4 | -34 | -7 | -2 | 6.9 | 14.7 | 41.1 | -28 | + 44 | + 32 | 102.0 | + 9 |
| Q3 | 12.9 | 42.1 | 26.5 | 34.1 | 81.4 | -33 | -6 | -2 | 7.7 | 15.4 | 41.6 | -28 | + 38 | + 28 | 118.0 | + 8 |
| Q4 | 12.6 | 42.8 | 27.5 | 34.9 | 81.7 | -32 | -6 | -3 | 8.3 | 16.3 | 42.7 | -27 | + 35 | + 24 | 128.1 | + 8 |
| Q5 (Least favored) | 12.2 | 42.3 | 28.6 | 36.5 | 81.8 | -32 | -6 | -3 | 8.6 | 16.9 | 43.4 | -28 | + 33 | + 23 | 135.0 | + 9 |
| Q1a < 54.8 | 11.3 | 43.6 | 27.5 | 34.5 | 82.3 | -32 | -7 | -2 | 8.5 | 16.3 | 43.3 | -25 | + 32 | + 25 | 109.5 | + 3 |
| Q2 54.8–88.1 | 15.4 | 42.7 | 26.5 | 34.2 | 81.9 | -33 | -6 | -2 | 7.5 | 15.1 | 40.6 | -25 | + 39 | + 31 | 143.9 | + 6 |
| Q3 88,1–178.1 | 13.3 | 42.4 | 27.6 | 35.5 | 82.0 | -33 | -6 | -2 | 8.3 | 17.3 | 44.6 | -29 | + 41 | + 27 | 132.5 | + 9 |
| Q4 > 178.1 | 24.0 | 40.2 | 24.0 | 31.7 | 78.5 | -35 | -7 | -3 | 6.4 | 13.5 | 39.4 | -31 | + 41 | + 30 | 200.6 | + 15 |
| Q1a < 233.2 | 12.9 | 43.3 | 27.3 | 34.3 | 82.4 | -32 | -7 | -2 | 8.3 | 16.2 | 43.5 | -25 | + 32 | + 26 | 121.2 | + 3 |
| Q2 233.2–352.8 | 13.6 | 43.3 | 27.0 | 34.8 | 81.9 | -33 | -7 | -2 | 7.7 | 15.1 | 39.8 | -25 | + 34 | + 27 | 130.8 | + 5 |
| Q3 352.8–511.0 | 17.8 | 41.1 | 26.1 | 33.9 | 80.7 | -33 | -7 | -3 | 7.4 | 15.7 | 42.4 | -30 | + 43 | + 29 | 160.9 | + 12 |
| Q4 > 511.0 | 19.9 | 40.8 | 24.2 | 32.0 | 78.8 | -35 | -7 | -3 | 6.7 | 14.1 | 40.5 | -31 | + 43 | + 32 | 173.7 | + 15 |
LD 1: First national lockdown W11-W18 (March 17 to May 10, 2020)
LD 2: Second national lockdown W44-W49 (October 30 to December 14, 2020)
aQuartile by are of residence, rate of hospitalization for COVID-19 per 100,000 people
Description of person characteristics with at least one consultation with physiotherapists and dentists during the lockdown periods and the whole of 2020 relative to the corresponding periods in 2019, for mainland France
| LD 1 | LD 2 | Year | LD 1 | LD 2 | Year | LD 1 | LD 2 | Year | LD 1 | LD 2 | Year | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020 Million | % | % | % | % | % | % | % | % | % | % | % | % | |
| 64.3 | 1.6 | 6.7 | 15.2 | -80 | -3 | -8 | 0.5 | 9.8 | 37.1 | -95 | 1 | -12 | |
| 0–1 | 1.4 | 0.6 | 1.1 | 7.0 | -86 | -44 | -44 | 0.0 | 0.5 | 1.7 | -95 | -3 | -14 |
| 2–6 | 3.7 | 0.1 | 0.5 | 1.2 | -83 | -11 | -24 | 0.2 | 7.1 | 29.9 | -97 | -5 | -13 |
| 7–17 | 8.4 | 0.3 | 2.4 | 6.2 | -89 | -9 | -17 | 0.9 | 9.2 | 40.1 | -92 | 0 | -15 |
| 18–25 | 5.8 | 0.5 | 3.0 | 8.5 | -86 | + 2 | -7 | 0.4 | 6.9 | 30.5 | -95 | + 8 | -12 |
| 26–50 | 20.0 | 1.1 | 6.1 | 14.5 | -84 | 0 | -9 | 0.6 | 10.6 | 39.1 | -95 | + 4 | -13 |
| 51–65 | 12.2 | 2.0 | 9.1 | 20.0 | -81 | -2 | -7 | 0.6 | 12.3 | 42.8 | -96 | 0 | -11 |
| 66–75 | 6.9 | 2.5 | 10.2 | 22.7 | -79 | -5 | -6 | 0.5 | 11.6 | 41.3 | -96 | 0 | -9 |
| 76–85 | 4.2 | 4.5 | 13.5 | 27.9 | -72 | -7 | -7 | 0.4 | 8.8 | 33.8 | -96 | -5 | -11 |
| > 85 | 1.8 | 8.6 | 16.6 | 31.0 | -57 | -2 | -1 | 0.2 | 4.0 | 18.0 | -97 | -8 | -12 |
| Male | 30.7 | 1.3 | 5.1 | 12.5 | -79 | -3 | -9 | 0.5 | 9.0 | 34.4 | -95 | + 1 | -12 |
| Female | 33.5 | 1.9 | 8.1 | 17.7 | -80 | -3 | -8 | 0.5 | 10.5 | 39.6 | -95 | + 1 | -12 |
| Q1(Most favored) | 12.6 | 1.7 | 7.4 | 16.3 | -80 | -3 | -7 | 0.5 | 10.6 | 40.7 | -95 | + 3 | -11 |
| Q2 | 12.9 | 1.8 | 7.4 | 16.6 | -80 | -2 | -8 | 0.5 | 10.3 | 38.8 | -95 | + 2 | -12 |
| Q3 | 12.9 | 1.7 | 7.1 | 16.1 | -79 | -2 | -8 | 0.5 | 9.9 | 37.5 | -95 | + 1 | -12 |
| Q4 | 12.6 | 1.5 | 6.2 | 14.4 | -79 | -4 | -9 | 0.6 | 9.4 | 35.4 | -95 | -1 | -13 |
| Q5 (Least favored) | 12.2 | 1.4 | 5.4 | 12.6 | -79 | -5 | -10 | 0.5 | 8.8 | 33.1 | -95 | -2 | -14 |
| Q1a < 54.8 | 11.3 | 1.8 | 7.2 | 16.5 | -79 | -2 | -8 | 0.5 | 10.0 | 37.6 | -95 | 0 | -13 |
| Q2 54.8–88.1 | 15.4 | 1.9 | 7.5 | 16.9 | -78 | -2 | -8 | 0.5 | 9.8 | 37.4 | -95 | + 1 | -12 |
| Q3 88.1–178.1 | 13.3 | 1.8 | 6.7 | 15.1 | -78 | -4 | -9 | 0.6 | 9.5 | 35.7 | -95 | -1 | -14 |
| Q4 > 178.1 | 24.0 | 1.3 | 5.9 | 13.5 | -82 | -4 | -8 | 0.5 | 9.9 | 37.5 | -95 | + 3 | -11 |
| Q1a < 233.2 | 12.9 | 1.8 | 7.3 | 16.5 | -79 | -1 | -8 | 0.5 | 10.0 | 37.7 | -96 | + 1 | -13 |
| Q2 233.2–352.8 | 13.6 | 1.9 | 7.3 | 16.5 | -78 | -3 | -8 | 0.6 | 9.8 | 36.9 | -95 | + 1 | -13 |
| Q3 352.8–511.0 | 17.8 | 1.6 | 6.2 | 14.0 | -78 | -5 | -9 | 1.6 | 9.4 | 35.7 | -95 | 0 | -13 |
| Q4 511.0 and above | 19.9 | 1.3 | 6.3 | 14.5 | -82 | -3 | -8 | 1.3 | 10.1 | 38.2 | -95 | + 2 | -11 |
LD 1: First national lockdown W11-W18 (March 17 to May 10, 2020)
LD 2: Second national lockdown W44-W49 (October 30 to December 14, 2020)
aQuartile by area of residence, rate of hospitalization for COVID-19 per 100,000 people
Description of person characteristics with at least one referral to medical specialists in 2020 relative to 2019 in mainland France
| Million | % | % | % | % | % | % | % | % | % | % | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 64.3 | 26.7 | -7 | 10.2 | -9 | 9.1 | -12 | 9.6 | -5 | 6.3 | -11 | |
| 0–1 | 1.4 | 6.2 | -13 | 0.1 | 31 | 2.4 | -17 | 0.7 | -7 | 5.4 | -26 |
| 2–6 | 3.7 | 21.8 | -10 | 0.0 | + 3 | 3.5 | -18 | 0.7 | -17 | 8.9 | -24 |
| 7–17 | 8.4 | 26.7 | -7 | 2.0 | -9 | 7.5 | -13 | 1.3 | -15 | 4.0 | -15 |
| 18–25 | 5.8 | 17.4 | -7 | 13.1 | -7 | 7.8 | -6 | 1.9 | -2 | 3.7 | -4 |
| 26–50 | 20.0 | 22.1 | -9 | 17.9 | -9 | 8.6 | -12 | 4.5 | -6 | 5.2 | -8 |
| 51–65 | 12.2 | 31.3 | -7 | 11.5 | -10 | 10.1 | -13 | 13.8 | -6 | 7.3 | -10 |
| 66–75 | 6.9 | 39.9 | -4 | 7.3 | -12 | 13.5 | -10 | 25.0 | -3 | 9.3 | -7 |
| 76–85 | 4.2 | 39.8 | -7 | 3.2 | -11 | 12.7 | -11 | 30.8 | -5 | 10.1 | -10 |
| > 85 | 1.8 | 22.9 | -8 | 0.7 | -9 | 7.0 | -12 | 20.2 | -5 | 6.9 | -11 |
| Male | 30.7 | 23.3 | -7 | 0.2 | + 6 | 7.5 | -11 | 10.4 | -5 | 6.2 | -10 |
| Female | 33.5 | 29.8 | -8 | 19.4 | -9 | 10.3 | -12 | 8.9 | -5 | 6.5 | -11 |
| Q1 (Post favored) | 12.6 | 28.8 | -7 | 13.6 | -9 | 12.5 | -11 | 10.1 | -5 | 7.7 | -11 |
| Q2 | 12.9 | 27.3 | -7 | 11.1 | -9 | 9.8 | -11 | 9.6 | -5 | 6.5 | -10 |
| Q3 | 12.9 | 26.7 | -8 | 10.1 | -9 | 8.9 | -11 | 9.8 | -5 | 6.3 | -10 |
| Q4 | 12.6 | 26.1 | -7 | 8.6 | -10 | 7.4 | -13 | 9.3 | -5 | 5.7 | -11 |
| Q5 (Least favored) | 12.2 | 25.0 | -7 | 7.6 | -11 | 6.3 | -14 | 9.4 | -6 | 5.6 | -12 |
| Q1c < 233.2 | 12.9 | 27.3 | -8 | 8.7 | -10 | 8.2 | -12 | 9.2 | -5 | 5.7 | -11 |
| Q2 233.2–352.8 | 13.6 | 27.1 | -8 | 8.7 | -10 | 8.2 | -12 | 9.2 | -5 | 5.7 | -11 |
| Q3 352.8–511.0 | 17.8 | 25.9 | -8 | 9.5 | -10 | 9.3 | -12 | 9.8 | -6 | 6.2 | -11 |
| Q4 > 511.0 | 19.9 | 26.8 | -7 | 10.3 | -9 | 8.1 | -12 | 9.3 | -5 | 6.1 | -11 |
Consul: percentage of patients with at less one consultation in 2020
2020/2019: difference between the two years in the percentage of patients with at least one annual consultation
aProportion of persons with at least one consultation in 2020
bRatio
cQuartile by area of residence, rate of hospitalization for COVID-19 per 100,000 people
Description of consultations with GPs and nurses during the first lockdown and for the whole of 2020 relative to the corresponding periods in 2019 and deaths in 2020 in mainland France, as a function of the disease identified in the 2019 and a morbidity index
| 2020% | mea | % | % | % | % | % | % | % | % | /100.000 | % | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Coronary disease | 3.2 | 72.3 | 47.6 | 89.5 | -21 | + 2 | 24.4 | 69.8 | -15 | + 11 | 5.1 | + 9 |
| Stroke | 1.4 | 72.2 | 44.1 | 83.1 | -22 | + 2 | 25.6 | 62.8 | -11 | + 12 | 6.9 | + 11 |
| Heart failure | 1.3 | 79.3 | 43.6 | 74.8 | -20 | 0 | 34.2 | 62.6 | -8 | + 6 | 12.3 | + 5 |
| Lower limb arteriopathy | 1.1 | 73.3 | 47.9 | 86.6 | -22 | 0 | 28.0 | 68.9 | -14 | + 7 | 7.6 | + 8 |
| Rhythm or conduction disturbances | 2.7 | 76.2 | 46.0 | 83.8 | -21 | + 2 | 31.0 | 68.3 | -12 | + 9 | 7.8 | + 7 |
| Valvular disease | 0.7 | 75.7 | 47.1 | 84.6 | -21 | + 1 | 34.6 | 70.8 | -10 | + 7 | 8.1 | + 6 |
| Acute pulmonary embolism | 0.1 | 69.6 | 43.8 | 78.4 | -20 | 0 | 28.1 | 63.0 | -12 | + 9 | 8.3 | + 5 |
| Actively treated | 2.2 | 68.4 | 39.9 | 80.8 | -22 | 0 | 31.7 | 69.8 | -9 | + 8 | 8.5 | + 2 |
| Monitored | 3.0 | 69.9 | 41.4 | 89.1 | -24 | + 2 | 21.1 | 68.6 | -18 | + 13 | 3.8 | + 13 |
| Psychotic disorders | 0.7 | 51.4 | 36.5 | 78.7 | -23 | 0 | 23.4 | 52.6 | -6 | + 13 | 2.9 | + 14 |
| Neurotic and mood disorders | 2.2 | 58.3 | 47.6 | 88.5 | -20 | + 1 | 20.6 | 59.8 | -15 | + 14 | 3.6 | + 11 |
| Manic and bipolar disorders | 0.4 | 56.1 | 44.6 | 88.6 | -20 | + 2 | 20.6 | 61.2 | -14 | + 15 | 2.3 | + 14 |
| Depression and mood disorders | 1.4 | 58.9 | 49.4 | 89.6 | -21 | -1 | 20.5 | 60.6 | -17 | + 12 | 3.5 | + 8 |
| Neurotic disorders | 0.8 | 57.8 | 47.3 | 87.2 | -19 | + 2 | 22.8 | 59.9 | -9 | + 16 | 4.7 | + 15 |
| Mental impairment | 0.2 | 41.4 | 31.6 | 77.0 | -29 | -2 | 14.2 | 44.3 | -15 | + 22 | 2.0 | + 17 |
| Addictive disorders | 0.7 | 51.0 | 42.9 | 82.4 | -17 | 0 | 17.6 | 52.5 | -13 | + 14 | 3.8 | + 6 |
| Childhood-onset disorders | 0.3 | 17.2 | 21.8 | 80.2 | -38 | + 3 | 4.6 | 28.0 | -20 | + 56 | 0.4 | + 12 |
| Dementia | 1.2 | 84.9 | 37.0 | 66.4 | -24 | -2 | 25.9 | 47.1 | -4 | + 11 | 16.2 | + 12 |
| Parkinson’s disease | 0.4 | 76.9 | 45.5 | 83.3 | -23 | 0 | 27.5 | 64.0 | -9 | + 10 | 9.8 | + 13 |
| Multiple sclerosis | 0.2 | 51.9 | 41.7 | 89.8 | -20 | + 2 | 21.4 | 68.4 | -19 | + 15 | 1.3 | + 2 |
| Paraplegia | 0.1 | 53.9 | 40.9 | 82.9 | -21 | + 1 | 26.4 | 61.7 | -10 | + 12 | 4.1 | + 5 |
| Myopathy or myasthenia gravis | 0.1 | 51.9 | 39.1 | 87.7 | -24 | + 1 | 18.7 | 61.5 | -19 | + 16 | 2.8 | + 5 |
| Epilepsy | 0.5 | 49.2 | 37.8 | 83.7 | -24 | + 1 | 16.5 | 51.0 | -15 | + 17 | 4.1 | + 10 |
| 0 | 2.1 | 67.0 | 29.5 | 88.2 | -39 | -3 | 6.7 | 19.8 | -47 | + 12 | 0.2 | + 8 |
| 1 | 4.0 | 69.1 | 32.4 | 88.9 | -34 | + 1 | 9.2 | 22.9 | -37 | + 15 | 0.4 | + 9 |
| 2 | 3.7 | 72.1 | 37.6 | 91.7 | -30 | + 2 | 13.4 | 27.8 | -29 | + 13 | 0.8 | + 16 |
| 3 | 3.1 | 75.7 | 42.0 | 93.0 | -29 | + 1 | 18.3 | 32.4 | -25 | + 10 | 1.5 | + 10 |
| 4 | 2.6 | 79.2 | 44.6 | 92.2 | -27 | + 1 | 24.1 | 36.8 | -20 | + 7 | 3.0 | + 12 |
| 5 | 2.0 | 82.1 | 46.3 | 89.5 | -25 | + 1 | 30.4 | 40.3 | -14 | + 7 | 5.5 | + 10 |
| 6 | 1.5 | 84.4 | 46.1 | 84.2 | -22 | + 2 | 34.7 | 40.5 | -8 | + 8 | 9.3 | + 11 |
| 7 | 1.0 | 86.2 | 44.0 | 77.2 | -21 | + 2 | 34.9 | 37.1 | -5 | + 9 | 13.3 | + 11 |
| 8 | 0.6 | 87.5 | 40.7 | 70.0 | -20 | + 1 | 32.9 | 32.6 | -3 | + 9 | 16.4 | + 10 |
| 9 | 0.6 | 88.8 | 36.1 | 60.8 | -19 | 0 | 30.0 | 27.4 | -2 | + 9 | 19.7 | + 8 |
LD 1: First national lockdown W11-W18 (March 17 to May 10, 2020)